Research Output per year
Fingerprint Dive into the research topics where Pedro Miguel Lacal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
temozolomide
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor-1
Medicine & Life Sciences
Vascular Endothelial Growth Factor A
Medicine & Life Sciences
Neuropilin-1
Medicine & Life Sciences
DNA Mismatch Repair
Medicine & Life Sciences
Monoclonal Antibodies
Medicine & Life Sciences
Endothelial Cells
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1987 2019
MiR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Caporali, S., Amaro, A., Levati, L., Alvino, E., Lacal, P. M., Mastroeni, S., Ruffini, F., Bonmassar, L., Antonini Cappellini, G. C., Felli, N., Carè, A., Pfeffer, U. & D'Atri, S., Jun 21 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 272.Research output: Contribution to journal › Article
Open Access
Vascular Endothelial Growth Factor A
Melanoma
Down-Regulation
MicroRNAs
Immunoblotting
6
Citations
(Scopus)
Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid
Ceci, C., Lacal, P. M., Tentori, L., De Martino, M. G., Miano, R. & Graziani, G., Nov 14 2018, In : Nutrients. 10, 11, 1756.Research output: Contribution to journal › Review article
Ellagic Acid
ellagic acid
drug therapy
neoplasms
Fruit
3
Citations
(Scopus)
Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells
Lacal, P. M., Atzori, M. G., Ruffini, F., Tentori, L. & Graziani, G., Jan 1 2018, In : Oncology Reports. 39, 5, p. 2261-2269 9 p.Research output: Contribution to journal › Article
Vascular Endothelial Growth Factor Receptor-1
Intercellular Signaling Peptides and Proteins
Growth
Monocytes
Extracellular Matrix
8
Citations
(Scopus)
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Lacal, P. M. & Graziani, G., Oct 1 2018, In : Pharmacological Research. 136, p. 97-107 11 p.Research output: Contribution to journal › Review article
Vascular Endothelial Growth Factor Receptor-1
Cellular Microenvironment
Tumor Microenvironment
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor A
3
Citations
(Scopus)
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
Abou Faycal, C., Brambilla, E., Agorreta, J., Lepeltier, N., Jacquet, T., Lemaître, N., Emadali, A., Lucas, A., Lacal, P. M., Montuenga, L., Pio, R., Gazzeri, S. & Eymin, B., Jun 1 2018, In : British Journal of Cancer. 118, 12, p. 1596-1608 13 p.Research output: Contribution to journal › Article
Vascular Endothelial Growth Factor Receptor-1
Integrins
Squamous Cell Carcinoma
Lung
Therapeutics